Ophthalmology
Research and innovation from Vanderbilt Eye Institute experts
Dual Approach to Intermittent Exotropia
A pair of surgeries for childhood intermittent exotropia, or “wandering eye,” demonstrate similar effectiveness, with some nuances.
Read MoreLatest in Ophthalmology
Gene Variations Linked to Glaucoma Risk
Risk variants of primary open-angle glaucoma may be ancestry-specific, sex-specific, or both.
New Leadership Brings Fresh Insights to Vision Care
Vanderbilt’s new chair of ophthalmology and visual sciences looks forward to the future of the Vanderbilt Eye Institute.
Predictors of Diabetic Retinopathy Under Scrutiny
Identifying specific inflammation mediators will help retina specialists anticipate and treat factors in retinopathy disease progression.
Partners in Care
Medical expertise infused with integrated technology allows Vanderbilt Health specialists to build partnerships and elevate care in complex and specialized cases. Browse our referral directory or log into our online portal for referring providers.
Make a ReferralExpanding VEI Program Helps Patients Thrive
Through comprehensive care and ongoing support, our low vision clinic helps children and adults with vision loss better navigate their environment.
Beagle Genomics Spark Advances in Human Glaucoma
Gene variant discovered to cause RGC degeneration in beagles with inherited disease also has causative effects in a mouse model.
Atropine Response Varies for Pediatric Myopia
NEI-funded trial finds low-dose eye drops may not be effective at slowing the progression of nearsightedness in some children.
Telehealth Overcomes Distance for Specialty Consultations
Neurology forges a wider path for specialty consulting services using technology.
Scleral Lenses a Good Fit for Complex Eye Diseases
With advances in fitting technology, scleral contact lenses are now being used for an increasingly wide range of therapeutic applications.
Promising Strategies for Treating Macular Degeneration
Durable injections, gene therapy, and a novel treatment for dry AMD aim to slow disease progression and decrease treatment burden.